BioMed Nexus
Trusted, targeted, transformative
The daily habit for 95,000+ leaders across Biotech, MedTech, and Clinical Research. Trusted by the institutions that build the industry.
95,365Active Subscribers
27.5%Current Open Rate
3.85%Click Through Rate
Read daily by decision makers at
Pfizer Moderna Mayo Clinic NIH Thermo Fisher Amgen Stanford Medicine
Why BioMed Nexus
🏛
Institutional Power: We don't just reach individuals; we saturate the buildings. We are the daily read for teams at Top Research Hospitals, The VA, and Biotech campuses.
🔬
From Lab to Launch: Our audience spans the entire lifecycle—from bench scientists and principal investigators to clinical directors and manufacturing leaders.
💼
The B2B Standard: With 68% of readers on verified Corporate/Academic domains, you are reaching professionals at work, not students at home.
🚀
Founder Access: We identify and reach the C-Suite of emerging biotechs building their tech stacks today.
Audience Snapshot
Active Subscribers
95,365
Verified Dec 2025
Budget Authority
$40B+
R&D and Commercial Spend
Click Through Rate
3.85%
High intent audience
Sectors
Biotech • Medtech
Devices • Pharma
End to end healthcare innovation
Geography
~70% U.S. / 30% Global
Investors, executives, R&D and clinical leaders
Frequency
5× per week
Trusted weekday habit
68.1% Corporate Density — Verified corporate and academic email domains
Audience Composition
A balanced ecosystem of Clinical, Research, and Industry professionals.
Clinical & Research Core ~23% Healthcare Providers ~13% Academic Researchers ~10% 2026 Industry Ownership Program
Secure "Title Rights" for global dominance, or "Segment Rights" for high-intent targeting.
One Partner • One Year • Global ExclusiveTitle Partner: "Presented By"
Total Brand Dominance
Your brand owns the masthead. 100% Share of Voice on the homepage and a Defensive Blockade against all category competitors. Secure the highest-visibility position in the industry—from the Lab Bench to the C-Suite.
$1,200,000 annual exclusive
1 Slot Available (Open for Interviews)
Schedule Partnership Briefing →- 100% Share of Voice: Top logo placement in every daily edition
- Global Blockade: We decline all ads from your direct competitors
- Institutional Presence: Visible to teams at top research hospitals and major biotech campuses daily
- Editorial Integration: Two "Deep Dive" feature stories per month
- Performance Safeguard: Included
Tier 2: Targeted Access Partners
⚠ In Negotiation
$400K
Per Year
Includes:
- Daily Native Insight Box
- Section Naming Rights
- Competitor Blockade
Available
$400K
Per Year
Includes:
- Daily Native Insight Box
- Section Naming Rights
- Competitor Blockade
⚠ In Negotiation
$350K
Per Year
Includes:
- Daily Native Insight Box
- Section Naming Rights
- Competitor Blockade
Flexible Partnership Options
Campaign-based and audience-specific programs for teams who need precision targeting or lower-commitment entry points.
$150K
Per Quarter (3-Month Campaign)
Includes:
- 3 Feature Stories
- Full Subscriber Distribution
- Lead Generation Asset
$50K
Quarterly Series
Includes:
- Thought Leadership Interview
- Weekend Edition Sponsorship
Performance and ROI
BioMed Nexus Exclusive
$1.2M
Approx. cost for similar reach and quality
Exclusive annual partnership
Equivalent engaged impressions
~6.6M opens / ~230K clicks
Open / CTR quality
27.5% open rate / 3.85% click through rate
Trade Pub Package
$1.6M–$2.2M
Endpoints, Fierce, STAT, BioCentury
Equivalent engaged impressions
~4.5M opens / ~90K clicks
Open / CTR quality
Around 20% open rate / about 1.5% click through rate
LinkedIn Clinical Targeting
$1.85M
Approx. cost for equivalent clicks
High intent Oncologist and Research targeting
Equivalent engaged impressions
~185K clicks (no opens reported)
Open / CTR quality
Black Box Metrics / 0.5–1% click through rate
Impact Equivalence
$1.2M–$1.8M comparable media value
Modeled against trade media and paid social using engaged open equivalents.
BioMed Nexus (≈6.6M annual opens)100%
Trade publication package~65%
LinkedIn targeted ads (CxO, life sciences)~50%
Outcome Scenarios
- 200–300 percent lift in LinkedIn engagement during activation months
- 25–40 percent increase in qualified inbound traffic to partner assets
- 10–20 direct business development inquiries per quarter from feature weeks
Editorial Ecosystem
Daily newsletter
→
Website hubs
→
LinkedIn
→
Conference coverage
Each partner receives integrated exposure across all BioMed Nexus channels, creating measurable, high frequency visibility with healthcare innovation leaders.
Proven Impact
"During our ASCO coverage, the partner feature drove a 27 percent click through increase and more than ten direct business development inquiries within 48 hours."
Recent partnership success, conference aligned campaign.
Trusted by the leaders who move science forward.
FAQs
- Is this a sponsorship?
- No. A sponsorship is a logo placement. This is an Integrated Partnership. You are not renting space; you are embedding your brand into the daily workflow of the industry's top decision-makers.
- How do you report performance?
- We provide quarterly dashboards with opens, click through rate, verified clicks, topic engagement, and optimization recommendations.
- What happens if engagement dips?
- We include a performance safeguard. If average opens fall below 20 percent for two consecutive quarters, we extend the partnership by one quarter at no cost.
- What makes BioMed Nexus different from trade publications?
- We deliver higher open rates and click through rates, a focused decision maker audience, and integrated editorial coverage. Our readers act on what they see, they are not passive consumers.
